Publications by authors named "Raymond Omollo"

Claim this Profile
R
Randomised controlled trial of fosfomycin in neonatal sepsis: pharmacokinetics and safety in relation to sodium overload.
Christina W Obiero, Phoebe Williams, Sheila Murunga, Johnstone Thitiri, Raymond Omollo

Arch Dis Child· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rifampicin and clarithromycin (extended release) versus rifampicin and streptomycin for limited Buruli ulcer lesions: a randomised, open-label, non-inferiority phase 3 trial.
Richard O Phillips, Jérôme Robert, Kabiru Mohamed Abass, William Thompson, Fred Stephen Sarfo, Raymond Omollo

Lancet· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics, Safety, and Efficacy of an Allometric Miltefosine Regimen for the Treatment of Visceral Leishmaniasis in Eastern African Children: An Open-label, Phase II Clinical Trial.
Jane Mbui, Joseph Olobo, Raymond Omollo, Alexandra Solomos, Anke E Kip, Truphosa Omollo

Clin Infect Dis· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long term outcomes and prognostics of visceral leishmaniasis in HIV infected patients with use of pentamidine as secondary prophylaxis based on CD4 level: a prospective cohort study in Ethiopia.
Ermias Diro, Tansy Edwards, Koert Ritmeijer, Helina Fikre, Charles Abongomera, Raymond Omollo

PLoS Negl Trop Dis· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Malaria, mental disorders, immunity and their inter-relationships - A cross sectional study in a household population in a health and demographic surveillance site in Kenya.
Rachel Jenkins, Michael Ong'echa, Caleb Othieno, Linnet Ongeri, Peter Sifuna, Raymond Omollo

EBioMedicine· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized trial of AmBisome monotherapy and AmBisome and miltefosine combination to treat visceral leishmaniasis in HIV co-infected patients in Ethiopia.
Ermias Diro, Severine Blesson, Tansy Edwards, Koert Ritmeijer, Helina Fikre, Raymond Omollo

PLoS Negl Trop Dis· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Malaria and mental disorder: a population study in an area endemic for malaria in Kenya.
Rachel Jenkins, Caleb Othieno, Linnet Ongeri, Michael Ongecha, Peter Sifuna, Raymond Omollo

World Psychiatry· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Effectiveness of Sodium Stibogluconate and Paromomycin Combination for the Treatment of Visceral Leishmaniasis in Eastern Africa: Results from a Pharmacovigilance Programme.
Robert Kimutai, Ahmed M Musa, Simon Njoroge, Raymond Omollo, Fabiana Alves

Clin Drug Investig· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of AmBisome in Combination with Sodium Stibogluconate or Miltefosine and Miltefosine Monotherapy for African Visceral Leishmaniasis: Phase II Randomized Trial.
Monique Wasunna, Simon Njenga, Manica Balasegaram, Neal Alexander, Raymond Omollo

PLoS Negl Trop Dis· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Common mental disorder in Nyanza province, Kenya in 2013 and its associated risk factors--an assessment of change since 2004, using a repeat household survey in a demographic surveillance site.
Rachel Jenkins, Caleb Othieno, Linnet Ongeri, Peter Sifuna, Michael Ongecha, Raymond Omollo

BMC Psychiatry· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Generalizing boundaries for triangular designs, and efficacy estimation at extended follow-ups.
Annabel Allison, Tansy Edwards, Raymond Omollo, Fabiana Alves, Dominic Magirr

Trials· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Probable Post Traumatic Stress Disorder in Kenya and Its Associated Risk Factors: A Cross-Sectional Household Survey.
Rachel Jenkins, Caleb Othieno, Raymond Omollo, Linnet Ongeri, Peter Sifuna

Int J Environ Res Public Health· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alcohol consumption and hazardous drinking in western Kenya--a household survey in a health and demographic surveillance site.
Rachel Jenkins, Caleb Othieno, Linnet Ongeri, David Kiima, Peter Sifuna, Raymond Omollo

BMC Psychiatry· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence of malaria parasites in adults and its determinants in malaria endemic area of Kisumu County, Kenya.
Rachel Jenkins, Raymond Omollo, Michael Ongecha, Peter Sifuna, Caleb Othieno

Malar J· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adult psychotic symptoms, their associated risk factors and changes in prevalence in men and women over a decade in a poor rural district of Kenya.
Rachel Jenkins, Caleb Othieno, Linnet Ongeri, Bernards Ogutu, Peter Sifuna, Raymond Omollo

Int J Environ Res Public Health· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of single dose versus multiple doses of AmBisome for treatment of visceral leishmaniasis in eastern Africa: a randomised trial.
Eltahir A G Khalil, Teklu Weldegebreal, Brima M Younis, Raymond Omollo, Ahmed M Musa

PLoS Negl Trop Dis· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Innovative approaches to clinical data management in resource limited settings using open-source technologies.
Raymond Omollo, Michael Ochieng, Brian Mutinda, Truphosa Omollo, Rhoda Owiti

PLoS Negl Trop Dis· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of two rapid diagnostic tests for visceral leishmaniasis in Kenya.
Jane Mbui, Monique Wasunna, Manica Balasegaram, Adrian Laussermayer, Rashid Juma, Raymond Omollo

PLoS Negl Trop Dis· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of artemether-lumefantrine and dihydroartemisinin-piperaquine in the treatment of uncomplicated Plasmodium falciparum malaria in Kenyan children aged less than five years: results of an open-label, randomized, single-centre study.
Bernhards R Ogutu, Kevin O Onyango, Nelly Koskei, Edgar K Omondi, John M Ongecha, Raymond Omollo

Malar J· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sodium stibogluconate (SSG) & paromomycin combination compared to SSG for visceral leishmaniasis in East Africa: a randomised controlled trial.
Ahmed Musa, Eltahir Khalil, Asrat Hailu, Joseph Olobo, Manica Balasegaram, Raymond Omollo

PLoS Negl Trop Dis· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of miltefosine alone and in combination with sodium stibogluconate and liposomal amphotericin B for the treatment of primary visceral leishmaniasis in East Africa: study protocol for a randomized controlled trial.
Raymond Omollo, Neal Alexander, Tansy Edwards, Eltahir A G Khalil, Brima M Younis

Trials· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single-dose liposomal amphotericin B (AmBisome®) for the treatment of visceral leishmaniasis in East Africa: study protocol for a randomized controlled trial.
Tansy Edwards, Raymond Omollo, Eltahir A G Khalil, Sisay Yifru, Brima Musa

Trials· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and effectiveness of meglumine antimoniate in the treatment of Ethiopian visceral leishmaniasis patients with and without HIV co-infection.
Workagegnehu Hailu, Teklu Weldegebreal, Zewdu Hurissa, Hailemariam Tafes, Raymond Omollo

Trans R Soc Trop Med Hyg· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Geographical variation in the response of visceral leishmaniasis to paromomycin in East Africa: a multicentre, open-label, randomized trial.
Asrat Hailu, Ahmed Musa, Monique Wasunna, Manica Balasegaram, Sisay Yifru, Raymond Omollo

PLoS Negl Trop Dis· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Paromomycin for the treatment of visceral leishmaniasis in Sudan: a randomized, open-label, dose-finding study.
Ahmed M Musa, Brima Younis, Ahmed Fadlalla, Catherine Royce, Manica Balasegaram, Raymond Omollo

PLoS Negl Trop Dis· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis